FHIR © HL7.org  |  Server Home  |  FHIR Server FHIR Server 3.7.22-SNAPSHOT  |  FHIR Version n/a  User: [n/a]

724007009: Crisaborole (substance)

Status: current, Not sufficiently defined by necessary conditions definition status (core metadata concept). Date: 31-Jul 2017. Module: SNOMED CT core

Descriptions:

Id Description Lang Type Status Case? Module
3434852015 Crisaborole (substance) en Fully specified name Active Entire term case insensitive (core metadata concept) SNOMED CT core
3434853013 Crisaborole en Synonym (core metadata concept) Active Entire term case insensitive (core metadata concept) SNOMED CT core

0 descendants.

Expanded Value Set

Outbound Relationships Type Target Active Characteristic Refinability Group Values
Crisaborole (substance) Is a Phosphodiesterase 4 inhibitor true Inferred relationship Some
Crisaborole (substance) This attribute specifies the behavior that a substance will exhibit or participate in, given the appropriate context. Phosphodiesterase 4 inhibitor (disposition) true Inferred relationship Some
Crisaborole (substance) Is a produit chimique catégorisé selon sa fonction false Inferred relationship Some
Crisaborole (substance) Is a Enzyme inhibitor false Inferred relationship Some
Crisaborole (substance) Is a éther false Inferred relationship Some
Crisaborole (substance) Is a Nitrile true Inferred relationship Some
Crisaborole (substance) Is a Substance with ether structure true Inferred relationship Some
Crisaborole (substance) Is a A grouper concept for substances that are used in medicinal products for medical treatment, and also psychoactive substances that have few or no legitimate medical uses or that are not legally available to the person using them. true Inferred relationship Some
Inbound Relationships Type Active Source Characteristic Refinability Group
Product containing crisaborole (medicinal product) The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. True Crisaborole (substance) Inferred relationship Some 1
Crisaborole-containing product in cutaneous dose form The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. True Crisaborole (substance) Inferred relationship Some 1
Product containing only crisaborole (medicinal product) The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. True Crisaborole (substance) Inferred relationship Some 1
Product containing only crisaborole in cutaneous dose form (medicinal product form) The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. True Crisaborole (substance) Inferred relationship Some 1
Crisaborole 20 mg/g cutaneous ointment The most specific description of a substance present in the manufactured dose form, before any dilution or transformation. It includes modifiers, such as salts, esters, polymers (e.g. pegylation), and/or solvates (including waters of hydration). True Crisaborole (substance) Inferred relationship Some 1
Crisaborole 20 mg/g cutaneous ointment This attribute represents an ingredient that is the part of the active ingredient that the strength of a given product is based upon. True Crisaborole (substance) Inferred relationship Some 1

This concept is not in any reference sets

Back to Start